Incidence and risk predictors for osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates

Introduction The aim of this study was to establish the incidence of bisphosphonate-related osteonecrosis of the jaws (BRONJ) in oncologic patients and to determine risk predictors with respect to this condition.